Clinical Trial Update: Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial comparing olanzapine to a comparator and placebo in bipolar I disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED